J Korean Med Sci. 2017 Aug;32(8):1215-1216. English.
Published online Jun 28, 2017.
© 2017 The Korean Academy of Medical Sciences.
Editorial

Increasing Burden of Nontuberculous Mycobacteria in Korea

Seung-Jung Kee and Soon-Pal Suh
    • Department of Laboratory Medicine, Chonnam National University Medical School and Hospital, Gwangju, Korea.
Received June 27, 2017; Accepted June 28, 2017.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Nontuberculous mycobacteria (NTM) are diverse microorganisms of genus Mycobacterium other than M. tuberculosis complex and M. leprae, which are ubiquitous in the environment such as tap water, swimming pools, natural water, room dust, and soil (1). NTM species has been relatively neglected compared to M. tuberculosis complex because NTM species rarely causes human infectious diseases and human-to-human transmission has never been reported to date. However, some of NTM species may cause pulmonary, lymphatic, skin, soft tissue, disseminated, and bone diseases in humans (2).

In the current issue of this journal, Kim et al. (3) reported that the annual rates of NTM isolation increased steadily from 23.9% in 2009 to 48.2% in 2015, at tertiary referral hospitals, south-eastern region of Korea. In addition, the incidence of NTM disease increased significantly from 6.8 to 12.9 per 100,000 patients during the same period, most of which was associated with pulmonary NTM disease (93.1%). Especially, the number of patients with pulmonary NTM disease per 100,000 patients increased over the study period, whereas the number with extrapulmonary NTM disease remained unchanged. This trend of increasing NTM isolation was also observed at other tertiary referral hospitals in Korea, the rates of which increased steadily from 21%–43% in the early 2000s to 47%–70% in the early 2010s (4, 5, 6, 7, 8). Moreover, the incidence of pulmonary NTM disease has been increasing worldwide including Korea (9, 10).

To date, however, the cause of this increasing trend remains unclear. The increasing rate of NTM isolation and disease is considered to be inversely associated with the decreasing rate of tuberculosis (TB) burden. This explanation is supported by Ide et al.'s study (11) reporting that the incidence of pulmonary NTM disease increased gradually from 4.6 to 10.1 per 100,000 people between 2001 and 2009 in Nagasaki, Japan, whereas the incidence of TB decreased from 32.9 to 22.1 per 100,000 people. On the contrary, the incidence of TB in Korea increased from 86 to 95 per 100,000 people over the same period, despite of the increased rate of NTM isolation and disease. This suggested that the distinct feature of pulmonary NTM disease in Korea as compared with that in Japan was the relatively high percentage of patients with a history of TB, leading to the speculation that structural lung damage by TB infection renders the host vulnerable to NTM disease rather than that exposure to TB provides cross-protection to NTM disease (9). The development of NTM disease has been reported to be associated with two distinct groups of risk factors (2): 1) host factors such as structural lung disease (e.g., chronic obstructive lung disease, and cystic fibrosis), history of TB, genetic susceptibility, immune defects (e.g., human immunodeficiency virus infection and immunosuppressive drugs), demographic characteristics (e.g., advanced age and male sex), lower body mass index, and higher comorbidity level; 2) environmental factors such as geographic characteristics (e.g., humidity and altitude) and aerosolized water exposure (e.g., showers and hot tubs). Collectively, combination of both host and environmental risk factors could contribute to this increasing trend of NTM isolation and disease.

Analyzing NTM species according to their isolation site, the authors (3) further reported that the most commonly isolated species among pulmonary specimens were M. intracellulare (38.9%), followed by M. avium (23.1%), M. abscessus (8.4%) and M. kansasii (7.7%), whereas those among extrapulmonary specimens were M. avium (25.0%), followed by M. fortuitum complex (20.9%) and M. intracellulare (16.6%). This is in line with previous studies from Korea (4, 5, 7, 8, 12). M. abscessus-massiliense complex is the second most common etiologic organism in pulmonary NTM disease in Korea (12). Because M. abscessus and M. massiliense are equally distributed within this complex in Korea and the treatment success rate is significantly higher in pulmonary NTM disease caused by M. massiliense compared to M. abscessus, precise identification of M. abscessus-massiliense complex to subspecies-level is very important. Sequencing of the hsp65, rpoB, and 16S-23S rRNA internal transcribed spacer genes is necessary, but these molecular methods are more costly and time-consuming. In the future, matrix-assisted laser desorption/ionization-time of flight mass spectrometry could be a rapid identification method for differentiation between M. abscessus and M. massiliense in clinical microbiology laboratories (13).

In conclusion, the rate of NTM isolation and disease has been increasing steadily in Korea. The most commonly isolated NTM species are M. avium-intracellulare complex and M. abscessus-massiliense complex. Therefore, the notification of NTM disease and the introduction of rapid method for subspecies-level identification of NTM to improve treatment success and prognosis of NTM disease are warranted in Korea.

Notes

DISCLOSURE:The authors have no potential conflicts of interest to disclose.

Author Contributions:

  • Conceptualization: Kee SJ, Suh SP.

  • Writing - original draft: Kee SJ, Suh SP.

  • Writing - review & editing: Kee SJ, Suh SP.

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367–416.
    1. Saleeb P, Olivier KN. Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Curr Infect Dis Rep 2010;12:198–203.
    1. Kim N, Yi J, Chang CL. Recovery rates of non-tuberculous mycobacteria from clinical specimens are increasing in Korean tertiary-care hospitals. J Korean Med Sci. 2017
      Forthcoming.
    1. Park YS, Lee CH, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 2010;14:1069–1071.
    1. Lee SK, Lee EJ, Kim SK, Chang J, Jeong SH, Kang YA. Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand J Infect Dis 2012;44:733–738.
    1. Yoo JW, Jo KW, Kim MN, Lee SD, Kim WS, Kim DS, Shim TS. Increasing trend of isolation of non-tuberculous mycobacteria in a tertiary university hospital in South Korea. Tuberc Respir Dis (Seoul) 2012;72:409–415.
    1. Kim JK, Rheem I. Identification and distribution of nontuberculous mycobacteria from 2005 to 2011 in Cheonan, Korea. Tuberc Respir Dis (Seoul) 2013;74:215–221.
    1. Koh WJ, Chang B, Jeong BH, Jeon K, Kim SY, Lee NY, Ki CS, Kwon OJ. Increasing recovery of nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea. Tuberc Respir Dis (Seoul) 2013;75:199–204.
    1. Simons S, van Ingen J, Hsueh PR, Van Hung N, Dekhuijzen PN, Boeree MJ, van Soolingen D. Nontuberculous mycobacteria in respiratory tract infections, Eastern Asia. Emerg Infect Dis 2011;17:343–349.
    1. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 2015;36:13–34.
    1. Ide S, Nakamura S, Yamamoto Y, Kohno Y, Fukuda Y, Ikeda H, Sasaki E, Yanagihara K, Higashiyama Y, Hashiguchi K, et al. Epidemiology and clinical features of pulmonary nontuberculous mycobacteriosis in Nagasaki, Japan. PLoS One 2015;10:e0128304.
    1. Kwon YS, Koh WJ. Diagnosis and treatment of nontuberculous mycobacterial lung disease. J Korean Med Sci 2016;31:649–659.
    1. Tseng SP, Teng SH, Lee PS, Wang CF, Yu JS, Lu PL. Rapid identification of M. abscessus and M. massiliense by MALDI-TOF mass spectrometry with a comparison to sequencing methods and antimicrobial susceptibility patterns. Future Microbiol 2013;8:1381–1389.

Metrics
Share
PERMALINK